- Home
- BUSE vs MANE Comparison
BUSE vs MANE Comparison
Compare BUSE & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BUSE | MANE |
|---|---|---|
| Founded | 1868 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | BUSE | MANE |
|---|---|---|
| Price | $26.93 | $73.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $27.00 | ★ $78.33 |
| AVG Volume (30 Days) | ★ 515.5K | 449.2K |
| Earning Date | 04-28-2026 | 03-30-2026 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $719,584,000.00 | N/A |
| Revenue This Year | $23.84 | N/A |
| Revenue Next Year | $3.82 | N/A |
| P/E Ratio | $18.34 | ★ N/A |
| Revenue Growth | ★ 55.66 | N/A |
| 52 Week Low | $19.91 | $36.26 |
| 52 Week High | $27.65 | $80.90 |
Technical Indicators
Market Signals| Indicator | BUSE | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 62.23 | 61.11 |
| Support Level | $23.39 | $54.23 |
| Resistance Level | $27.09 | N/A |
| Average True Range (ATR) | 0.48 | 6.13 |
| MACD | 0.10 | 0.69 |
| Stochastic Oscillator | 85.71 | 72.08 |
Price Performance
Historical ComparisonAbout BUSE First Busey Corporation
First Busey Corporation is a financial holding company whose subsidiaries provide retail and commercial banking services, remittance processing, and offer financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.